CD4 and B-cell chronic lymphocytic leukemia: At the 6‐month timepoint, the longevity of the CD4+ T‐cell responses in these latter groups (solid organ transplant and chronic lymphocytic leukemia) was not sustained as well as responses seen in healthy individuals or the other immunocompromised groups.